Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2005
08/17/2005CN1653885A Method for obtaining amphihaploid plant of pumpkin ovule and its special culture medium
08/17/2005CN1215083C Monoclonal antibody for resisting human liver cancer and its application
08/16/2005US6930226 Nucleotide sequences coding polypeptide for use in the adjustment of the starch concentration in plant
08/16/2005US6930224 by way of transfecting and/or regenerating plant material under specified culture conditions which prevent or reduce the rate of or delay the rise in pH of the culture medium
08/16/2005US6930182 Composition and methods of using the Mirabilis mosaic caulimovirus sub-genomic transcript (Sgt) promoter for plant genetic engineering
08/16/2005US6930174 CCR5 chemokine receptor-specific antibodies
08/16/2005US6930172 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2005US6930169 Reducing induced apoptosis; obtain sample, incubate with modulator, monitor sample for reduction in apoptitic activity
08/16/2005US6930094 Tissue factor for influencing blood vessel formation
08/16/2005US6929948 Lineage specific cells and progenitor cells
08/16/2005US6929947 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2005US6929938 25501, a human transferase family member and uses therefor
08/16/2005US6929937 Human transferase proteins and polynucleotides encoding the same
08/16/2005US6929933 genes for riboflavin biosynthesis in yeast, the proteins encoded therewith and genetic engineering process for the preparation of riboflavin starting from GTP using these genes and gene products
08/16/2005US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing
08/16/2005US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections
08/16/2005US6929924 eliminates all interference due to proinsulin and its intermediates, in particular des-31,32-proinsulin and/or des-64,65-proinsulin
08/16/2005US6929921 Antibody which binds human blue-light photoreceptor hCRY2
08/16/2005US6929907 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay
08/16/2005US6929792 administering to a patient genetically modified dendritic cells which are to express on the cell surface, an E/L-selectin chimera that contains the transmembrane and intracellular domains of L-selectin and extracellular domain of E-selectin
08/16/2005CA2141025C Anti-mucus glycoprotein monoclonal antibody
08/16/2005CA2084075C The ciliary neurotrophic factor receptor
08/11/2005WO2005073396A1 Plant cells having receptor polypeptides
08/11/2005WO2005073395A1 Method of examining ability to regulate the expression of neprilysin activity
08/11/2005WO2005073386A1 Composition and method for immobilizing genetic material on support and transferring into cell
08/11/2005WO2005073366A1 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof
08/11/2005WO2005073365A1 Method of treating cells for transplantation, cell suspension, prosthesis for transplantation and method of treating injured site
08/11/2005WO2005072764A2 Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
08/11/2005WO2005072515A1 High lycopene tomato varieties and use thereof
08/11/2005WO2005072364A2 A modified baculovirus expression system for production of pseudotyped raav vector
08/11/2005WO2005072125A2 Composite materials for controlled release of water soluble products
08/11/2005WO2005072112A2 Methods for producing and identifying multispecific antibodies
08/11/2005WO2005059119A3 Differentiated cells
08/11/2005WO2005046617A3 Compositions and methods for reducing microbial induced apoptosis
08/11/2005WO2005039662A3 Cartilage regeneration by generation of chondrons under high concentrations of magnesium
08/11/2005WO2004101758A3 Composition for maintaining organ and cell viability
08/11/2005WO2004094602A3 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
08/11/2005WO2004088283A3 Apparatus and methods for providing sex-sorted animal sperm
08/11/2005WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders
08/11/2005WO2004050842A3 Atm kinase compositions and methods
08/11/2005WO2004030626A3 In vitro culture of tissue structures
08/11/2005WO2004009766A3 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
08/11/2005WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
08/11/2005WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
08/11/2005US20050177904 Inbred corn line D603
08/11/2005US20050177895 Inbred corn line KW4U110
08/11/2005US20050177894 Inbred corn line D501
08/11/2005US20050177893 Transcription factors and methods for introduction of value-added seed traits and stress tolerance
08/11/2005US20050177890 Transposon being functional in mammals
08/11/2005US20050177882 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/11/2005US20050176946 Constitutive promoter from Arabidopsis
08/11/2005US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders
08/11/2005US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents
08/11/2005US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents
08/11/2005US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis
08/11/2005US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs
08/11/2005US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus
08/11/2005US20050176147 Method for obtaining a cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
08/11/2005US20050176144 Culture media compositions free of fetal bovine serum
08/11/2005US20050176143 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/11/2005US20050176142 Mammalian megakaryocyte progenitor cell
08/11/2005US20050176141 Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
08/11/2005US20050176140 Method and apparatus for cell culture using a two liquid phase bioreactor
08/11/2005US20050176137 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/11/2005US20050176132 Culture device and method for eukaryotic cell transfection
08/11/2005US20050176129 Adenovirus vector
08/11/2005US20050176117 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids
08/11/2005US20050176104 Using overexpression of nucleotide sequences coding tumor associated antigen as diagnostic/prognostic tool in detection of cancer
08/11/2005US20050176102 Totipotent hematopoietic stem cell receptors and their ligands
08/11/2005US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor
08/11/2005US20050176083 Blood protein fusion comprising serine-protease (SP) domain for use in treatment of thrombosis a nd blood coagulation disorders
08/11/2005US20050176044 Polynucleotides and polypeptides encoding receptors
08/11/2005US20050176041 Using membrane proteins as tool in diagnosis, prevention and treatment of cell proliferative disorders
08/11/2005US20050176022 Vertebrate telomerase genes and proteins and uses thereof
08/11/2005US20050176018 Increased nuclease resistance; gene expression inhibition
08/11/2005US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics
08/11/2005US20050176005 Functional ligand display
08/11/2005US20050175986 Human monoclonal antibody
08/11/2005US20050175978 Methods and devices for mecroencapsulation of cells
08/11/2005US20050175976 Meiosis activating sterol augments implantation rate
08/11/2005US20050175705 Modified reconstituted basement membrane composition for assay system
08/11/2005US20050175606 Cyclic single-chain trispecific antibody
08/11/2005US20050175599 Process for producing substance
08/11/2005US20050175596 Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells
08/11/2005US20050175590 Viral expression vectors
08/11/2005US20050175587 Inhibits cancer cell growth especially epithelial cancer cell growth; host cell and a drug containing the vector; for the treatment of cancers, by gene therapy
08/11/2005US20050173315 Tangential flow filtration devices and methods for leukocyte enrichment
08/11/2005DE102004025080A1 Method for testing substances for their effects on cells, useful e.g. in screening for pharmaceuticals or cosmetics, using organoid bodies derived from adult stem cells
08/11/2005CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
08/11/2005CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof
08/11/2005CA2554410A1 Biotherapeutics, diagnostics and research reagents
08/11/2005CA2554403A1 Gastrointestinal proliferative factor and uses thereof
08/11/2005CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction
08/10/2005EP1561822A1 Detection of DNA damaging agents
08/10/2005EP1561817A2 Modified CEA and uses thereof
08/10/2005EP1561815A2 Tissue-specific and target rna-specific ribozymes
08/10/2005EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division
08/10/2005EP1560916A1 Expansion agents for stem cells
08/10/2005EP1560915A2 Assay methods for state-dependent calcium channel agonists/antagonists
08/10/2005EP1560587A1 Cholesterol efflux and uses thereof